Literature DB >> 9009131

Chemolysis of gallbladder debris left over after contact litholysis with methyl tert-butyl ether.

U Wosiewitz1, F Sabinski, U Leuschner.   

Abstract

Rapid and safe gallbladder clearance from residual, post-MTBE stone debris is believed to be absolutely necessary to reduce stone recurrence after contact litholysis. Because the clearing effect of prokinetic agents is considered an uncertain postdissolution trial, we investigated by in vitro experiments whether and to what extent debris from various cholesterol and "mixed stones" could be removed by direct (topical) chemolysis. Debris from radiolucent cholesterol stones could be dissolved very easily, using the aqueous solvent S-01, composed of EDTA-2Na (1-2%), lauryl sulfobetaine-12 (0.1 M), and 0.1 M sodium carbonate/boric acid buffer, pH 9,5. Its dissolution capacity (DC) was 8.06 +/- 2.3 mg debris/ml and its dissolution efficacy (DE) was 16.2 +/- 4.6 mg debris/ml/hr. Debris from mixed, slightly to moderately calcified stones needed another treatment with S-05, composed of sodium citrate (0.25 M), lauryl sulfobetaine-12 (0.01 M), and citric acid. The initial pH was 5.2. The DC of S-05 ranged from 1.61 +/- 1.1 (debris enriched with Ca-phosphate) to 3.94 +/- 1.3 mg/ml (debris enriched with Ca-carbonate). Stones which did not respond immediately to MTBE because of a thin rim of inorganic or/and organic Ca salts could be made ready for MTBE litholysis by pretreatment with S-01 or S-05 or with a combination of both solvents. Debris containing large portions of biliary mucus could be dissolved most effectively by successive application of S-01 and S-06 (2 M urea).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009131     DOI: 10.1023/a:1018805726491

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  The anatomy of gallstones.

Authors:  N A WOMACK; R ZEPPA; G L IRVIN
Journal:  Ann Surg       Date:  1963-05       Impact factor: 12.969

2.  Fragmentation of gallstones using extracorporeal shock waves: an in vitro study.

Authors:  R Schachler; T Sauerbruch; U Wosiewitz; J Holl; D Hahn; R Denk; M Neubrand; G Paumgartner
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

3.  Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis.

Authors:  S P Lee
Journal:  J Pathol       Date:  1981-07       Impact factor: 7.996

4.  Effect of mucous glycoprotein on nucleation time of human bile.

Authors:  S Gallinger; R D Taylor; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

5.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

6.  Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile.

Authors:  B F Smith
Journal:  J Lipid Res       Date:  1987-09       Impact factor: 5.922

7.  Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy.

Authors:  B W Trotman; T A Morris; H M Sanchez; R D Soloway; J D Ostrow
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

8.  Mucus hypersecretion in the gallbladder epithelium of ground squirrels fed a lithogenic diet for the induction of cholesterol gallstones.

Authors:  R S Pemsingh; B R MacPherson; G W Scott
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

9.  Alternating treatment of common bile duct stones with a modified glyceryl-1-monooctanoate preparation and a bile acid-EDTA solution by nasobiliary tube.

Authors:  U Leuschner; D Wurbs; H Baumgärtel; E B Helm; M Classen
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

10.  Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application.

Authors:  J L Thistle; G L Carlson; A F Hofmann; N F LaRusso; R L MacCarty; G L Flynn; W I Higuchi; V K Babayan
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.